Ovarian failure and strategies for fertility preservation in patients with systemic lupus erythematosus

Pasoto SG , Viana VST , Mendonca BB. Anti-corpus luteum antibody: a novel serological marker for ovarian dysfunction in systemic lupus erythematosus? J Rheumatol 1999; 26: 1087-1093 .

Raz A , Fish B , Okon E. Possible direct cytoxicity effects of cyclophosphamide on cultures of human follicles: an electron microscopy study . J Assist Reprod Genet 2002; 19: 500-506 .

Boumpas DT , Austin HA , Vaughan EM et al. Risc for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy . Ann Intern Med 1993; 119: 366-369 .

Lim GS , Petri M , Goldman D. Menstruation and systemic lupus erythematosus: a case control study . Arthritis Rheum 1993; 36 (Suppl. 5): R23-R23 .

Wang CL , Wang F , Bosco JJ. Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus . Lupus 1995; 4: 11-14 .

McDermott EM , Powell RI. Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide . Ann Rheum Dis 1996; 55: 224-229 .

Pasoto SG , Mendonca BB , Bonfa E. Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations . Lupus 2002; 11: 175-180 .

Moncayo R , Moncayo HE. Autoimmunity and the ovary . Immunol Today 1992; 13: 255-258 .

Moncayo R , Moncayo H. Serum levels of CA 125 are elevated in patients with systemic lupus erythematosus . Obstet Gynecol 1991; 77: 932-934 .

Jacobi AM , Rohde W , Ventz M et al. Enchanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity . Lupus 2000; 10: 554-561 .

Jimena P , Aguirre MA , Lopez-Curbelo A. Prolactin levels in patients with systemic lupus erythematosus: a case controlled study . Lupus 1998; 7: 383-386 .

Leanos A , Pascal D. Anti-prolactin autoantibodies in SLE patients with associated hyperprolactinemia . Lupus 1998; 7: 398-403 .

Rovensky J , Jurankova E , Rauova L. Relationship between endocrine, immune and clinical variables in patients with systemic lupus erythematosus . J Rheumatol 1997; 24: 2330-2334 .

Flanc RS , Roberts MA , Strippoli GF et al. Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials . Am J Kidney Dis 2004; 43: 197-208 .

Gonzalez MR , Gomez JJ , Merino R. Mensrual disorders in girls with systemic lupus erythematosus treated with cyclophosphamide . Br J Rheumatol 1995; 34: 737-741 .

McDermott EM , Powell RJ. Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide . Ann Rheum Dis 1996; 55: 224-229 .

Ioannidis JP , Katsifis GE , Tzioufas AG , Moutsopoulos HM. Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopauseal women with systemic lupus erythematosus . J Rheumatol 2002; 29: 2129-2135 .

Takada K , Arefayene M , Desta Z et al. Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis . Arthritis Rheum 2004; 50: 2202-2210 .

Meirow D , Lewis H , Nugent D , Epstein M. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool . Hum Reprod 1999; 14: 1903-1907 .

Meirow D , Epstein M , Lewis H , Nugent D , Gosden RG. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations . Hum Reprod 2001; 16: 632-637 .

Letterie GS. Anovulation in the prevention of cytotoxic-induced follicular attrition and ovarian failure . Hum Reprod 2004; 19: 831-837 .

Wallace WH , Shalet SM , Tetlow LJ. Ovarian function following the treatment of childhood acute lymphoblastic leukaemia . Med Pediatr Oncol 1993; 21: 333-339 .

Park M-C , Park Y-B , Jung SY et al. Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy . Lupus 2004; 13: 569-574 .

Huong DLT , Amoura Z , Duhaut P et al. Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients . J Rheumatol 2002; 29: 2571-2576 .

Slater CA , Liang MH , McCune JW , Christman GM , Laufer MR. Preserving ovarian function in patients receiving cyclophosphamide . Lupus 1999; 8: 3-10 .

Meirow D , Assad G , Dor J , Rabinovici J. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice . Hum Reprod 2004; 19: 1294-1299 .

Dooley MA , Pattterson CC , Susan L et al. Preservation of ovarian function using depot leuprolide acetate during cyclophosphamide therapy for severe lupus nephritis . Arthritis Rheum 2000; 43: 2858-2858 .

Dooley MA , Falk RJ , Jennette JC et al. Variable bone mineral density changes in women receiving depot leuprolide acetate during cyclophosphamide therapy for severe lupus nephritis . Arthritis Rheum 1998; 40 (Suppl. 9): Abstract.

Blumenfeld Z , Shapiro D , Shteinberg M , Avivi I , Nahir M. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated with chemotherapy . Lupus 2000; 9: 401-405 .

Ghosh S , Monomohon M , Baran D et al. Effect of human chorionic gonadotrophin coadministration on ovarian steroidogenic and folloculogenic activities in cyclophosphamide treated albino rats . Reprod Toxicol 2001; 15: 221-225 .

Pendse S , Ginsburg E , Singh AK. Strategies for preservation of ovarian and testicular function after immunosupression . Am J Kidney Dis 2004; 43: 772-781 .

Blumenfeld Z. Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and -B as markers . Mol Cell Endocrinol 2002; 187: 93-105 .

Masala A , Faedda R , Alagna S et al. Use of testosterone to prevent cyclophosphamide-induced azoospermia . Ann Intern Med 1997: 15; 126: 292-295 .

Howell SJ , Shalet SM. Testicular function following chemotherapy . Hum Reprod Update 2001; 7: 363-369 .

Contreras G , Pardo V , Baudouin L et al. Sequential therapies for proliferative lupus nephritis . N Engl J Med 2004; 350: 971-980 .

Chan TM , Li FK , Colin SO et al. Efficacy of mycophenolate mofetil in patients with diffuseproliferative lupus nephritis . N Engl J Med 2000; 343: 1156-1162 .

Balow JE , Austin HA. Maintenance therapy for lupus nephritis - something old, something new . N Engl J Med 2004; 350: 1044-1046 .

Looney RJ , Anolik J , Sanz I. B lymphocytes in systemic lupus erythematosus: lessons from therapy targeting B cells . Lupus 2004; 13: 381-390 .

Gorman C , Leandro M , Isenberg D. Does B cell depletion have a role to play in the treatment of systemic lupus erythematosus? Lupus 2004; 13: 312-316 .

Weide R , Heymanns J , Randorf A , Koppler H. Successful long-term treatment of SLE with rituximab maintenance therapy . Lupus 2003; 12: 779-782 .